Wanda Cui on measuring ovarian toxicity

Professor Sherene Loi and the International Immuno-Oncology Biomarker Working Group on tumour-infiltrating lymphocytes as breast cancer biomarkers. Two Articles cover AI and digital pathology scoring methods and a Review examines integrating TILs into radiation oncology trials an ...  Show more

5-year quality of life (QOL) substudy of the SUPREMO trial examining the effects of chest wall radiotherapy versus no chest wall radiotherapy after mastectomy in patients with intermediate-risk breast cancer. The data will put patients in a better position to make an informed tre ...  Show more

In this episode, we review the high-yield topic of ⁠Ovarian ...

Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers. 

In this episode of PodMD, experienced sub-specialist Gynaecological Oncologist Dr Rhett Morton will be discussing the topic of ovarian cancer, including how a patient would typically present, the treatment options available, the warning signs to look out for, the likelihood of ...

Send us Fan MailWelcome to The Oncology Journal Club Podcast Series 3Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology NetworkWelcome to Episode 7 of The Oncology Journal Club podcast. This is where we take a fa ...  Show more